Perrigo Company plc (NYSE:PRGO) Shares Acquired by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC boosted its stake in Perrigo Company plc (NYSE:PRGO) by 10.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 304,948 shares of the company’s stock after purchasing an additional 28,843 shares during the period. Nisa Investment Advisors LLC owned approximately 0.22% of Perrigo worth $7,840,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Perrigo by 2.1% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 21,617 shares of the company’s stock valued at $567,000 after buying an additional 436 shares during the period. Voisard Asset Management Group Inc. raised its stake in shares of Perrigo by 9.7% during the third quarter. Voisard Asset Management Group Inc. now owns 5,100 shares of the company’s stock valued at $134,000 after purchasing an additional 450 shares during the period. Central Pacific Bank Trust Division lifted its position in shares of Perrigo by 33.3% during the fourth quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company’s stock worth $51,000 after purchasing an additional 500 shares in the last quarter. Creative Planning boosted its stake in shares of Perrigo by 3.7% in the third quarter. Creative Planning now owns 18,477 shares of the company’s stock valued at $485,000 after purchasing an additional 661 shares during the period. Finally, KBC Group NV grew its holdings in Perrigo by 25.1% during the 3rd quarter. KBC Group NV now owns 4,517 shares of the company’s stock valued at $118,000 after purchasing an additional 905 shares in the last quarter. 95.91% of the stock is owned by hedge funds and other institutional investors.

Perrigo Trading Up 2.8 %

Perrigo stock opened at $24.73 on Friday. Perrigo Company plc has a 52-week low of $23.14 and a 52-week high of $33.67. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. The firm has a market capitalization of $3.37 billion, a price-to-earnings ratio of -21.14 and a beta of 0.53. The firm has a 50-day moving average price of $26.30 and a two-hundred day moving average price of $26.68.

Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.81 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.81. The business had revenue of $1.09 billion during the quarter, compared to analyst estimates of $1.12 billion. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business’s revenue for the quarter was down 3.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.64 EPS. Sell-side analysts expect that Perrigo Company plc will post 2.56 earnings per share for the current year.

Perrigo Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Friday, November 29th were given a dividend of $0.276 per share. The ex-dividend date was Friday, November 29th. This represents a $1.10 dividend on an annualized basis and a dividend yield of 4.46%. Perrigo’s dividend payout ratio (DPR) is -94.02%.

Insider Transactions at Perrigo

In other news, Director Jeffrey B. Kindler sold 17,598 shares of the company’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $28.27, for a total value of $497,495.46. Following the completion of the sale, the director now owns 5,409 shares in the company, valued at $152,912.43. This represents a 76.49 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on PRGO. Piper Sandler cut shares of Perrigo from an “overweight” rating to a “neutral” rating and decreased their price objective for the company from $34.00 to $27.00 in a research report on Monday, January 6th. StockNews.com downgraded Perrigo from a “buy” rating to a “hold” rating in a report on Saturday, January 11th. Argus lowered Perrigo from a “buy” rating to a “hold” rating in a research report on Tuesday, January 14th. Finally, Canaccord Genuity Group restated a “buy” rating and issued a $42.00 price target on shares of Perrigo in a research report on Monday, September 30th. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Perrigo currently has a consensus rating of “Hold” and a consensus target price of $35.00.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.